Professor Jonathan Emberson
Jonathan Emberson
BA, MSc, PhD
Professor of Medical Statistics and Epidemiology
- MRC Population Health Research Unit Programme Leader
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. He is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Recent publications
-
Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease
Journal article
Mayne K. et al, (2023), Journal of the American Society of Nephrology
-
Independent relevance of adiposity measures to coronary heart disease risk among 0.5 million adults in UK Biobank.
Journal article
Trichia E. et al, (2023), Int J Epidemiol
-
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol
-
Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Journal article
Ziyatdinov A. et al, (2023), Nature
-
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
Journal article
Wijesurendra RS. et al, (2023), Eur Heart J